Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Technologies Raises $10.8M in Funding Round

SAN FRANCISCO, Dec. 3 – NuGen Technologies, a privately-held San Carlos, Calif., genetic analysis company, raised $10.8 million in Series B financing, the company announced Monday.

The investor group was led by Pequot Ventures, an investment arm of Pequot Capital Management, based in Westport, Conn. Additional investors included SoftBank LifeScience Ventures, Radius Venture Partners, MedCapital, Band of Angels Fund, and Tenex Medical Investors.

In November 2000, NuGen raised $2 million in Series A financing, led by Tenex Medical Investors, based in Burlingame, Calif.  

NuGen, founded February 2000, has developed a nucleic acid amplification system utilizing its single primer isothermal amplification (SPIA) technology, according to the company.

“SPIA has broad applications spanning industries from life science research, to food safety, to environmental testing,” Jan D'Alvise, CEO of NuGen, said in a statement. “We will form strategic alliances to serve our principal market interests - life science research and diagnostics - and license to deliver SPIA to markets beyond this core focus. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.